These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 19300276

  • 21. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS, Natale A, di Bona G, Calvi V, Santarelli P, Manzoli U.
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [Abstract] [Full Text] [Related]

  • 22. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ, Best TH, Eswaran H, Lowery CL.
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P, Brembilla-Perrot B, Fauchier JP, Babuty D, Garnier LF, Rouesnel P, Breuillac JC, Funck F, Scheck F, Peraudeau P, Medvedowsky JL.
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [Abstract] [Full Text] [Related]

  • 24. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ.
    Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397
    [Abstract] [Full Text] [Related]

  • 25. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 25; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 26. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C, Busi G.
    G Ital Cardiol; 1996 Apr 25; 26(4):419-25. PubMed ID: 8707026
    [Abstract] [Full Text] [Related]

  • 27. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr 25; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 28. Supraventricular tachycardia resistant to treatment in a pregnant woman.
    Treakle K, Kostic B, Hulkower S.
    J Fam Pract; 1992 Nov 25; 35(5):581-4. PubMed ID: 1431774
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L, Alvarez A, Cianciulli T, Quiroga J, Califano J, Mautner B.
    Arch Inst Cardiol Mex; 1989 Nov 25; 59(3):241-4. PubMed ID: 2506843
    [Abstract] [Full Text] [Related]

  • 30. Supraventricular tachycardia with hydrops in a 27-week premature baby.
    Abraham P.
    Int J Clin Pract; 2001 Oct 25; 55(8):569-70. PubMed ID: 11695082
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
    Fauchier JP, Cosnay P, Néel C, Rouesnel P, Bonnet P, Quilliet L.
    Arch Mal Coeur Vaiss; 1985 Apr 25; 78(4):612-9. PubMed ID: 3923987
    [Abstract] [Full Text] [Related]

  • 33. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 25; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
    Ebenroth ES, Cordes TM, Darragh RK.
    Pediatr Cardiol; 2001 Jun 25; 22(6):483-7. PubMed ID: 11894150
    [Abstract] [Full Text] [Related]

  • 37. [Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect].
    Saoudi N, Berland J, Cribier A, Letac B.
    Arch Mal Coeur Vaiss; 1988 Apr 25; 81(4):537-41. PubMed ID: 3136716
    [Abstract] [Full Text] [Related]

  • 38. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A, Kaya B, Bornaun H, Acar DK, Avci ME, Bestel A, Yildirim G.
    J Matern Fetal Neonatal Med; 2018 Feb 25; 31(4):407-412. PubMed ID: 28114840
    [Abstract] [Full Text] [Related]

  • 39. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
    O'Brien JF, Tremml GP, Falk JL.
    Am J Emerg Med; 1996 Jan 25; 14(1):50-2. PubMed ID: 8630157
    [Abstract] [Full Text] [Related]

  • 40. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.